Skip to Main content
Number of documents

61

David Blum


Journal articles59 documents

  • Iain Hartnell, David Blum, James Nicoll, Guillaume Dorothee, Delphine Boche. Glial cells and adaptive immunity in frontotemporal dementia with tau pathology. Brain - A Journal of Neurology , Oxford University Press (OUP), 2021, ⟨10.1093/brain/awaa457⟩. ⟨hal-03156966⟩
  • Philibert Duriez, Sabiha Eddarkaoui, David Blum, Suzanne Dickson, Philip Gorwood, et al.. Does physical activity associated with chronic food restriction alleviate anxiety like behaviour, in female mice?. Hormones and Behavior, Elsevier, 2020, 124, pp.104807. ⟨10.1016/j.yhbeh.2020.104807⟩. ⟨inserm-03048737⟩
  • Tariq Ahmed, Ann van der Jeugd, Raphaëlle Caillierez, Luc Buée, David Blum, et al.. Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy. Frontiers in Molecular Neuroscience, Frontiers Media, 2020, 13, pp.570223. ⟨10.3389/fnmol.2020.570223⟩. ⟨inserm-02999926⟩
  • Eric Boué-Grabot, David Blum, Stefania Ceruti. Editorial: Purinergic Signaling in Health and Disease. Frontiers in Cellular Neuroscience, Frontiers, 2020, 14, ⟨10.3389/fncel.2020.00015⟩. ⟨hal-02541233⟩
  • Victoria Gomez-Murcia, Ursula Sandau, Barbara Ferry, Sandrine Parrot, Cyril Laurent, et al.. Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy. Neurobiology of Aging, Elsevier, 2020, 94, pp.265-270. ⟨10.1016/j.neurobiolaging.2020.06.004⟩. ⟨hal-03065490⟩
  • Laetitia Degiorgis, Meltem Karatas, Marion Sourty, Emilie Faivre, Julien Lamy, et al.. Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 mice. Brain - A Journal of Neurology , Oxford University Press (OUP), 2020, ⟨10.1093/brain/awaa312⟩. ⟨hal-03086057⟩
  • Ouada Nebie, Lassina Barro, Yu-Wen Wu, Folke Knutson, Luc Buee, et al.. Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro. Platelets, Taylor & Francis, 2020, 1, pp.1-12. ⟨10.1080/09537104.2020.1732324⟩. ⟨hal-02541219⟩
  • Annerieke Sierksma, Ashley Lu, Renzo Mancuso, Nicola Fattorelli, Nicola Thrupp, et al.. Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology. EMBO Molecular Medicine, Wiley Open Access, 2020, pp.e10606. ⟨10.15252/emmm.201910606⟩. ⟨inserm-02450349⟩
  • Antoine Leboucher, Tariq Ahmed, Emilie Caron, Anne Tailleux, Sylvie Raison, et al.. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model. Neurobiology of Disease, Elsevier, 2019, 125, pp.14-22. ⟨10.1016/j.nbd.2019.01.008⟩. ⟨inserm-02350072⟩
  • Kevin Carvalho, Emilie Faivre, Marie Pietrowski, Xavier Marques, Victoria Gomez-Murcia, et al.. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain - A Journal of Neurology , Oxford University Press (OUP), 2019, 142 (11), pp.3636-3654. ⟨10.1093/brain/awz288⟩. ⟨inserm-02350065⟩
  • Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean-Christophe Devedjian, et al.. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science, BioMed Central, 2019, 26 (1), pp.89. ⟨10.1186/s12929-019-0579-9⟩. ⟨inserm-02348443⟩
  • Stefania Zappettini, Emilie Faivre, Antoine Ghestem, Sébastien Carrier, Luc Buee, et al.. Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy. Frontiers in Cellular Neuroscience, Frontiers, 2019, 13, pp.438. ⟨10.3389/fncel.2019.00438⟩. ⟨inserm-02350061⟩
  • Nicolas Sergeant, Valérie Vingtdeux, Sabiha Eddarkaoui, Marion Gay, Caroline Evrard, et al.. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease. Neurobiology of Disease, Elsevier, 2019, 129, pp.217-233. ⟨10.1016/j.nbd.2019.03.028⟩. ⟨inserm-02350071⟩
  • Isabel Paiva, Kévin Carvalho, Patricia Santos, Lucrezia Cellai, Maria Angeliki S. Pavlou, et al.. A2A R‐induced transcriptional deregulation in astrocytes: An in vitro study. Glia, Wiley, 2019, 67 (12), pp.2329-2342. ⟨10.1002/glia.23688⟩. ⟨inserm-02350068⟩
  • Enrico Faldini, Tariq Ahmed, Luc Buée, David Blum, Detlef Balschun. Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2019, 7 (1), pp.202. ⟨10.1186/s40478-019-0813-4⟩. ⟨hal-02413632⟩
  • Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean-Christophe Devedjian, et al.. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science, BioMed Central, 2019, 26 (1), pp.89. ⟨10.1186/s12929-019-0579-9⟩. ⟨inserm-02350063⟩
  • Christina Ising, Carmen Venegas, Shuangshuang Zhang, Hannah Scheiblich, Susanne Schmidt, et al.. NLRP3 inflammasome activation drives tau pathology. Nature, Nature Publishing Group, 2019, 575 (7784), pp.669-673. ⟨10.1038/s41586-019-1769-z⟩. ⟨hal-02413609⟩
  • Stefania Zappettini, Emilie Faivre, Antoine Ghestem, Sébastien Carrier, Luc Buee, et al.. Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy. Frontiers in Cellular Neuroscience, Frontiers, 2019, 13, pp.438. ⟨10.3389/fncel.2019.00438⟩. ⟨inserm-02348452⟩
  • Amina Chaalal, Roseline Poirier, David Blum, Serge Laroche, Valérie Enderlin. Thyroid Hormone Supplementation Restores Spatial Memory, Hippocampal Markers of Neuroinflammation, Plasticity-Related Signaling Molecules, and β-Amyloid Peptide Load in Hypothyroid Rats. Molecular Neurobiology, Humana Press, 2019, 56 (1), pp.722-735. ⟨10.1007/s12035-018-1111-z⟩. ⟨inserm-01833290⟩
  • Mariana Ferreira, Diana Ferreira, Vânia Batalha, Inês Marques-Morgado, Joana Coelho, et al.. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry, Nature Publishing Group, 2018, ⟨10.1038/s41380-018-0110-9⟩. ⟨inserm-01833281⟩
  • Aurélie Joly-Amado, Maud Gratuze, Hamza Benderradji, Didier Vieau, Luc Buee, et al.. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies]. médecine/sciences, EDP Sciences, 2018, 34 (11), pp.929-935. ⟨10.1051/medsci/2018238⟩. ⟨inserm-02350074⟩
  • Andrea Popelová, Veronika Pražienková, Barbora Neprašová, Barbora Judita Kasperová, Lucie Hrubá, et al.. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy. Journal of Alzheimer's Disease, IOS Press, 2018, 62 (4), pp.1725-1736. ⟨10.3233/JAD-171041⟩. ⟨hal-03093235⟩
  • Snehajyoti Chatterjee, Raphaelle Cassel, Anne Schneider‐anthony, Karine Merienne, Brigitte Cosquer, et al.. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (11), ⟨10.15252/emmm.201708587⟩. ⟨hal-03060274⟩
  • Maud Gratuze, Aurélie Joly-Amado, Didier Vieau, Luc Buée, David Blum. Mutual relationship between Tau and central insulin signalling: consequences for AD and Tauopathies ?. Neuroendocrinology, Karger, 2018, ⟨10.1159/000487641⟩. ⟨inserm-01833302⟩
  • David Blum, Yijuang Chern, Maria Rosaria Domenici, Luc Buée, Chien-Yu Lin, et al.. The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease. Journal of Caffeine and Adenosine Research, New Rochelle, N.Y. : Mary Ann Liebert, Inc., [2018]-, 2018, 8 (2), pp.43 - 58. ⟨10.1089/caff.2018.0006⟩. ⟨inserm-01930490⟩
  • Emilie Faivre, Joana Coelho, Katja Zornbach, Enas Malik, Younis Baqi, et al.. Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease. Frontiers in Molecular Neuroscience, Frontiers Media, 2018, 11, pp.235. ⟨10.3389/fnmol.2018.00235⟩. ⟨inserm-01930489⟩
  • Snehajyoti Chatterjee, Raphaelle Cassel, Anne Schneider‐anthony, Karine Mérienne, Brigitte Cosquer, et al.. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (11), pp.e8587. ⟨10.15252/emmm.201708587⟩. ⟨inserm-01930486⟩
  • Lucrezia Cellai, Kevin Carvalho, Emilie Faivre, Aude Deleau, Didier Vieau, et al.. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease. Frontiers in Neuroscience, Frontiers, 2018, 12, pp.520. ⟨10.3389/fnins.2018.00520⟩. ⟨inserm-02350079⟩
  • Annerieke Sierksma, Ashley Lu, Evgenia Salta, Elke Vanden Eynden, Zsuzsanna Callaerts-Vegh, et al.. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration, BioMed Central, 2018, 13 (1), pp.54. ⟨10.1186/s13024-018-0285-1⟩. ⟨inserm-02350076⟩
  • Cyril Laurent, Luc Buée, David Blum. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?. Biomedical journal, Elsevier, 2018, 41 (1), pp.21 - 33. ⟨10.1016/j.bj.2018.01.003⟩. ⟨inserm-01833293⟩
  • Annerieke Sierksma, Ashley Lu, Evgenia Salta, Elke Vanden Eynden, Zsuzsanna Callaerts-Vegh, et al.. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration, BioMed Central, 2018, 13 (1), pp.54. ⟨10.1186/s13024-018-0285-1⟩. ⟨inserm-01930483⟩
  • Luc Cellai, Kevin Carvalho, Emilie Faivre, Aude Deleau, Didier Vieau, et al.. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease. Frontiers in Neuroscience, Frontiers, 2018, 12, pp.520. ⟨10.3389/fnins.2018.00520⟩. ⟨inserm-01930487⟩
  • Andrea Popelová, Veronika Pražienková, Barbora Neprašová, Barbora Judita Kasperová, Lucie Hrubá, et al.. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy. Journal of Alzheimer's Disease, IOS Press, 2018, 62 (4), pp.1725 - 1736. ⟨10.3233/JAD-171041⟩. ⟨inserm-01833299⟩
  • Chia-Chia Lee, Ching-Pang Chang, Chun-Jung Lin, Hsing-Lin Lai, Yu-Han Kao, et al.. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease. Molecular Neurobiology, Humana Press, 2018, ⟨10.1007/s12035-018-1030-z⟩. ⟨inserm-01833298⟩
  • Pauline Vercruysse, Didier Vieau, David Blum, Åsa Petersén, Luc Dupuis. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Frontiers in Molecular Neuroscience, Frontiers Media, 2018, 11, ⟨10.3389/fnmol.2018.00002⟩. ⟨inserm-01833308⟩
  • Cyrille Vandenbussche, Cynthia van der Hauwaert, Edmone Dewaeles, Jessica Franczak, Marie-Flore Mari, et al.. Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. Archives of Toxicology, Springer Verlag, 2018, 92 (4), pp.1539 - 1550. ⟨10.1007/s00204-018-2158-3⟩. ⟨inserm-01833311⟩
  • Aurélie Joly-Amado, Maud Gratuze, Hamza Benderradji, Didier Vieau, Luc Buée, et al.. Relation mutuelle entre Tau et signalisation centrale de l’insuline. médecine/sciences, EDP Sciences, 2018, 34 (11), pp.929-935. ⟨10.1051/medsci/2018238⟩. ⟨inserm-01958478⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2017, 5 (1), ⟨10.1186/s40478-017-0489-6⟩. ⟨hal-03093243⟩
  • Romain Duroux, Nicolas Renault, Joana Esteves, Laurence Agouridas, David Blum, et al.. Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A2A receptor. Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2017, 32 (1), pp.850-864. ⟨10.1080/14756366.2017.1334648⟩. ⟨hal-02060508⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2017, 5 (1), ⟨10.1186/s40478-017-0489-6⟩. ⟨inserm-01833336⟩
  • Jean-Baptiste Gibier, Brigitte Hemon, Melanie Fanchon, Kelly Gaudelot, Nicolas Pottier, et al.. Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2017, 1863 (6), pp.1336 - 1349. ⟨10.1016/j.bbadis.2017.03.023⟩. ⟨inserm-01833348⟩
  • Elodie Marciniak, Antoine Leboucher, Emilie Caron, Tariq Ahmed, Anne Tailleux, et al.. Tau deletion promotes brain insulin resistance. Journal of Experimental Medicine, Rockefeller University Press, 2017, 214 (8), pp.2257 - 2269. ⟨10.1084/jem.20161731⟩. ⟨inserm-01833342⟩
  • Cyril Laurent, Guillaume Dorothee, Stéphane Hunot, Elodie Martin, Cecile Delarasse, et al.. Tau et troubles cognitifs. médecine/sciences, EDP Sciences, 2017, 33 (10), pp.817 - 819. ⟨10.1051/medsci/20173310002⟩. ⟨inserm-01833339⟩
  • Wesley Chen, Edsel Abud, Stephen Yeung, Anita Lakatos, Trevor Nassi, et al.. Increased tauopathy drives microglia-mediated clearance of beta-amyloid. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2016, 4 (1), ⟨10.1186/s40478-016-0336-1⟩. ⟨inserm-01833353⟩
  • Vânia Batalha, Diana Ferreira, Joana Coelho, Jorge Valadas, Rui Gomes, et al.. mRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance. Journal of Molecular Neuroscience, Humana Press, 2016, 58 (4), pp.411-415. ⟨10.1007/s12031-015-0699-y⟩. ⟨hal-02541224⟩
  • Cyril Laurent, Guillaume Dorothee, Stéphane Hunot, Elodie Martin, Yann Monnet, et al.. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain - A Journal of Neurology , Oxford University Press (OUP), 2016, 140 (1), pp.184 - 200. ⟨10.1093/brain/aww270⟩. ⟨inserm-01833350⟩
  • Vânia Batalha, Diana Ferreira, Joana Coelho, Jorge Valadas, Rui Gomes, et al.. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports, Nature Publishing Group, 2016, 6 (1), ⟨10.1038/srep31493⟩. ⟨inserm-01833352⟩
  • Véronique Paban, Béatrice Loriod, Claude Villard, Luc Buee, David Blum, et al.. Omics analysis of mouse brain models of human diseases. Gene, Elsevier, 2016, 600, pp.90 - 100. ⟨10.1016/j.gene.2016.11.022⟩. ⟨hal-01433082⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana M. Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2016, 5 (1), pp.91. ⟨10.1186/s40478-017-0489-6⟩. ⟨inserm-01654098⟩
  • Valeria Moas Heloire, Nicolas Renault, Vânia Batalha, Angela Rincon Arias, Mathieu Marchivie, et al.. Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines. European Journal of Medicinal Chemistry, Elsevier, 2015, 106, pp.15-25. ⟨10.1016/j.ejmech.2015.10.030⟩. ⟨hal-02060788⟩
  • Sophie Ayciriex, Marie-Anne Burlot, Jérome Braudeau, Kristin Michaelsen-Preusse, Brigitte Potier, et al.. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Human Molecular Genetics, Oxford University Press (OUP), 2015, 24 (21), pp.5965 - 5976. ⟨10.1093/hmg/ddv268⟩. ⟨hal-01779042⟩
  • Maxime Derisbourg, Coline Leghay, Giovanni Chiappetta, Francisco-Jose Fernandez-Gomez, Cyril Laurent, et al.. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms. Scientific Reports, Nature Publishing Group, 2015, 5 (1), ⟨10.1038/srep09659⟩. ⟨hal-01659458⟩
  • Amina Chaalal, Roseline Poirier, David Blum, Brigitte Gillet, Pascale Le Blanc, et al.. PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments.. Hippocampus, Wiley, 2014, 24 (11), pp.1381-93. ⟨10.1002/hipo.22319⟩. ⟨hal-01165538⟩
  • Kunie Ando, Pierre Dourlen, Anne-Véronique Sambo, Alexis Bretteville, Karim Bélarbi, et al.. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.. Neurobiol Aging, 2013, 34 (3), pp.757-69. ⟨10.1016/j.neurobiolaging.2012.08.004⟩. ⟨hal-00765859⟩
  • Laëticia Troquier, Raphaëlle Caillierez, Sylvie Burnouf, Francisco Fernandez-Gomez, Marie-Eve Grosjean, et al.. Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.: Active Tau immunotherapy. Curr Alzheimer Res, 2012, 9 (4), pp.397-405. ⟨inserm-00664452⟩
  • Sébastien Feuillette, Vincent Deramecourt, Annie Laquérriere, Charles Duyckaerts, Marie-Bernadette Delisle, et al.. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains. Brain Research, Elsevier, 2010, 1345, pp.182-189. ⟨10.1016/j.brainres.2010.05.007⟩. ⟨hal-02329958⟩
  • Luc Buée, David Blum, Stephanie Bombois, Valérie Buée-Scherrer, Marie-Laure Caillet-Boudin, et al.. Comment les acteurs moléculaires de la pathologie Alzheimer permettent de comprendre la démence ? Quelles conséquences diagnostiques et thérapeutiques ?. Alternative and Complementary Therapies, Mary Ann Liebert, 2010, 65 (5), pp.401-407. ⟨10.2515/therapie/2010054⟩. ⟨hal-03093376⟩
  • Karim Belarbi, Katharina Schindowski, Sylvie Burnouf, Raphaëlle Caillierez, Marie-Eve Grosjean, et al.. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.. Current Alzheimer Research, Bentham Science Publishers, 2009, 6 (2), pp.152-7. ⟨inserm-00375282⟩
  • David Blum, Fiona Hemming, Marie-Christine Galas, Sakina Torch, Laetitia Cuvelier, et al.. Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid.. Neuroscience Letters, Elsevier, 2004, 368 (3), pp.309-13. ⟨10.1016/j.neulet.2004.07.046⟩. ⟨inserm-00381837⟩

Book sections2 documents